Michael May

President and CEO

Michael May picture

Michael May

CCRM

President and CEO

Michael May is President and CEO of CCRM, a Canadian NFP that develops technologies, launches new companies and catalyzes investment in the field of regenerative medicine, including cell and gene therapy. Prior to CCRM, Michael was the President and co-founder of Rimon Therapeutics Ltd., a Toronto-based tissue engineering company developing novel medical polymers that possess drug-like activity.

Michael sits on a number of boards and advisory committees including: the ARM Foundation for Cell & Gene Medicine; AgeX Corporation; panCELLa Inc.; the IAB of the Swedish Centre for Advanced Medical Products; the Poietis SAB; the Entrepreneurship Leadership Council at the University of Toronto; the Cell and Gene Therapy Insights Editorial Board; the Commercialization.Committee of ISCT. He is the Chairman of ExCellThera Ltd.

Dr. May completed his PhD in Chemical Engineering at UofT in 1998 as an NSERC Scholar and was awarded the Martin Walmsley Fellowship for Technological Entrepreneurship.